Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...
TNBC, aggressive and lacking key receptors, complicates treatment, impacting prognosis and requiring specialized approaches.